Solid lipid nanoparticles: a promising tool for insulin delivery.

Fatemeh MohammadpourHossein KamaliLeila GholamiAlice P McCloskeyPrashant Kesharwani Amir Hossein Sahebkar

Published in: Expert opinion on drug delivery (2022)

SLNs have proven to be safe and versatile drug delivery systems suitable for insulin delivery and capable of improving the efficacy and pharmacokinetic profile of encapsulated insulin. There is still some work to be done to fully explore SLNs' true potential as drug delivery and specifically insulin delivery vehicles suitable for clinical use.

Keyphrases

type diabetes
glycemic control
drug delivery
insulin resistance
metabolic syndrome
risk assessment
cancer therapy
climate change
skeletal muscle
weight loss